Safety Rates Drug Report: Trastuzumab General physical health deterioration adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Drug: Trastuzumab Injury: General physical health deterioration Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 7 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
103844203	Trastuzumab	General physical health deterioration	ROCHE	45.00 YR	F	72 KG	20160928	DE
109648479	Trastuzumab	General physical health deterioration	ROCHE	57.00 YR	F	77 KG	20160920	DE
113812079	Trastuzumab	General physical health deterioration	ROCHE	56.00 YR	F	85 KG	20160927	DE
120907702	TRASTUZUMAB	General physical health deterioration	NOVARTIS	55.00 YR	F	0	20160726	DE
123214502	Trastuzumab	General physical health deterioration	ROCHE	52.00 YR	F	79 KG	20160708	DE
125697632	trastuzumab	General physical health deterioration	CELGENE	56.00 YR		54 KG	20160802	DE
992844515	Trastuzumab	General physical health deterioration	ROCHE	78.90 YR	F	0	20160701	FR

|< 1/2 << Previous Page Page 1

Total Records: 7 Number of Pages: 1